Modelling prognostic factors in advanced pancreatic cancer.

Modelling prognostic factors in advanced pancreatic cancer.

Pancreatic cancer is the fifth most common cause of cancer death. Identification of defined patient groups based on a prognostic index may improve the prediction of survival and selection of therapy. Many prognostic factors have been identified often based on retrospective, underpowered studies with...

Bibliografski detalji
Glavni autori:	Stocken, D, Hassan, A, Altman, D, Billingham, L, Bramhall, SR, Johnson, P, Freemantle, N
Format:	Journal article
Jezik:	English
Izdano:	2008

Slični predmeti

Choice of transformation for modelling non-linear continuous biomarkers
od: Stocken Deborah D, i dr.
Izdano: (2011-12-01)

A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
od: Markham, C, i dr.
Izdano: (2003)

Acute pancreatitis: current perspectives on diagnosis and management
od: Shah AP, i dr.
Izdano: (2018-03-01)

Prognostic models: a methodological framework and review of models for breast cancer.
od: Altman, D
Izdano: (2009)

Advancing Prognostication in Pancreatic Cancer: A Comprehensive Cohort Analysis
od: Shikhar Tripathi, i dr.
Izdano: (2024-09-01)

Locally Advanced and Metastatic Pancreatic Cancer: Survival analysis and prognostic factors in a case series
od: Paloma Porto Amorim, i dr.
Izdano: (2020-01-01)

Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
od: Young Hoon Choi, i dr.
Izdano: (2021-03-01)

Sample Size Calculations for Designing Clinical Proteomic Profiling Studies Using Mass Spectrometry
od: Nyangoma, S, i dr.
Izdano: (2012)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
od: Taxiarchis Botsis, i dr.
Izdano: (2010-01-01)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
od: Taxiarchis Botsis, i dr.
Izdano: (2009-01-01)

Identification of clinically useful cancer prognostic factors: what are we missing?
od: McShane, L, i dr.
Izdano: (2005)

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy
od: Yue Ma, i dr.
Izdano: (2024-12-01)

Reporting performance of prognostic models in cancer: a review.
od: Mallett, S, i dr.
Izdano: (2010)

A prognostic model for ovarian cancer.
od: Clark, T, i dr.
Izdano: (2001)

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
od: Chiang Kun-Chun, i dr.
Izdano: (2012-05-01)

Comment on ‘exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy’
od: Jiaqing Wang, i dr.
Izdano: (2024-12-01)

Developing a prognostic model in the presence of missing data: an ovarian cancer case study.
od: Clark, T, i dr.
Izdano: (2003)

Reporting methods in studies developing prognostic models in cancer: a review.
od: Mallett, S, i dr.
Izdano: (2010)

Prognosis and prognostic research: Developing a prognostic model
od: Royston, P, i dr.
Izdano: (2009)

Prognosis and prognostic research: validating a prognostic model.
od: Altman, D, i dr.
Izdano: (2009)

Prognosis and prognostic research: Developing a prognostic model.
od: Royston, P, i dr.
Izdano: (2009)

Prognosis and prognostic research: Validating a prognostic model
od: Altman, D, i dr.
Izdano: (2009)

Prognosis and prognostic research: validating a prognostic model.
od: Altman, D, i dr.
Izdano: (2009)

Pancreatic neuroendocrine tumors: prognostic factors
od: Javier A. Cienfuegos, i dr.

The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
od: Byung Min Lee, i dr.
Izdano: (2018-05-01)

Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients
od: Alessandro Bittoni, i dr.
Izdano: (2021-09-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
od: Chang Min Cho
Izdano: (2018-05-01)

Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis
od: Dandan Jin, i dr.
Izdano: (2020-06-01)

A prognostic model for anoikis-related genes in pancreatic cancer
od: Wenbin Song, i dr.
Izdano: (2024-07-01)

Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer
od: Yangdong Wu, i dr.
Izdano: (2023-06-01)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
od: Dominik Andreas Barth, i dr.
Izdano: (2020-08-01)

Prediction and identification of synergistic compound combinations against pancreatic cancer cells
od: Yasaman KalantarMotamedi, i dr.
Izdano: (2021-09-01)

Prognosis and prognostic research: application and impact of prognostic models in clinical practice.
od: Moons, K, i dr.
Izdano: (2009)

Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
Izdano: (2013-09-01)

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature
od: Konstantin Schlick, i dr.
Izdano: (2021-10-01)

External validation of a Cox prognostic model: principles and methods.
od: Royston, P, i dr.
Izdano: (2013)

What do we mean by validating a prognostic model?
od: Altman, D, i dr.
Izdano: (2000)

Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
od: A. A. Klunichenko, i dr.
Izdano: (2020-07-01)

Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
od: Aurélie Courtin, i dr.
Izdano: (2013-01-01)

Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
od: Topkan E, i dr.
Izdano: (2019-10-01)